Anti-diabetogenic effect of the human amylin analogue, pramlintide, in Type 1 diabetes is not mediated by GLP-1

Research output: Contribution to journalJournal articleResearchpeer-review

B Ahrén, N Adner, J Svartberg, E Petrella, Jens Juul Holst, M K Gutniak

Original languageEnglish
JournalDiabetic Medicine
Volume19
Issue number9
Pages (from-to)790-2
Number of pages3
ISSN0742-3071
Publication statusPublished - Sep 2002

    Research areas

  • Adult, Amyloid, Blood Glucose, Diabetes Mellitus, Type 1, Female, Glucagon, Glucagon-Like Peptide 1, Humans, Hyperglycemia, Hypoglycemic Agents, Islet Amyloid Polypeptide, Male, Peptide Fragments, Protein Precursors

ID: 132056414